Key Takeaways UnitedHealth Group is set to report fourth-quarter earnings before the market opens Thursday.All 17 analysts tracked by Visible Alpha have a “buy” or equivalent rating and the consensus price target suggests a close to 10% rise in the shares is expected.

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it had made less than analysts expected.

UnitedHealth Group Inc. on Thursday posted higher earnings for the fourth quarter of 2024, but revenue fell short of Wall Street targets.

UnitedHealth shares tumbled Thursday after the health insurer reported fourth-quarter results below Wall Street’s expectations and issued a lackluster outlook. Monitor these key post-earnings price levels.

UnitedHealth Group CEO Andrew Witty told analysts that the company is positioned well for growth in 2025. This comes just a month after the CEO of its insurance unit was murdered.

UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S. needs to be "less confusing, less complex and less costly" during the company's first earnings call since the murder of Brian Thompson,

The video above originally aired on Dec. 13, 2024 NEW YORK CITY (PIX11) – A small group of protesters took to Wall Street Thursday as UnitedHealth Group released a financial

UnitedHealth posted a better-than-expected fourth-quarter profit, but a nagging rise in medical costs and care utilization surprised Wall Street.

Global shares are mostly higher following a rally on Wall Street driven by encouraging update on U.S. inflation. Oil prices slipped and U.S. futures edged higher.

In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its shares to fall in early morning trading despite quarterly profit beating projections.

UnitedHealth Group Incorporated (NYSE:UNH) dropped its share prices by 6.04 percent on Thursday to end at $510.59 apiece following twin news of worse-than-expected revenues and that it was overcharging patients by more than 1,000 percent for key life-saving drugs.

Witty's comments came during the company's first earnings call since the killing of Brian Thompson, the CEO of the company's insurance arm UnitedHealthcare.